/Companies

BioMarin

1 known investors

Find your way into BioMarin

Sign up to see every warm intro you have to BioMarin

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BioMarin team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.

Investors · 1

In the news

Frequently asked questions

What does BioMarin do?
BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.
Who are BioMarin's investors?
BioMarin's investors include Ridgeback Capital.